Creative Medical TechnologyCELZ
13F holders, Q2 2025 (June 30)12holders +1
4new positions
3sold out
1famous investor
$2.65avg. 13F price*
At the end of Q2 2025, 12 institutions reported holding Creative Medical Technology (CELZ) in their 13F filings, up 1 from Q1 2025. 4 opened new positions and 3 sold out. The largest holders were Geode Capital Management, LLC ($55K), Vanguard Group Inc. ($47K) and Northern Trust Corp. ($31K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Creative Medical Technology
- CUSIP
- 22529Y408
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $77K |
| Exits | 3 | $349K |
All 13F filers, Q1 2025 → Q2 2025: 31,747 shares bought and 163,387 shares sold, net −131,640 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Geode Capital Management, LLC | 0.00% | Add +14.3% | 20,876 | $55K |
| Vanguard Group Inc. | 0.00% | No change | 17,629 | $47K |
| Northern Trust Corp. | 0.00% | New | 11,707 | $31K |
| Citadel Advisors | 0.00% | New | 11,145 | $30K |
| Allworth Financial LP | 0.00% | New | 4,000 | $11K |
| Ameritas Advisory Services, LLC | 0.00% | New | 2,276 | $6K |
| Osaic Holdings, Inc. | 0.00% | Reduce -10.4% | 1,130 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -67.3% | 1,029 | $3K |
| Bank of America Corp. | 0.00% | Add +9.0% | 133 | $352 |
| Morgan Stanley | 0.00% | No change | 20 | $53 |
| UBS Group AG | 0.00% | No change | 2 | $5 |
| TD Waterhouse Canada Inc. | 0.00% | No change | 1 | $3 |
"% of holder's portfolio" is CELZ's weight in each manager's 13F, not the share of Creative Medical Technology the manager owns.